PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece. Electronic address: madalamaga@med.uoa.gr.\', \'Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece; Second Department of Critical Care, Attikon General University Hospital, Medical School, National and Kapodistrian University of Athens, Chaidari, Greece.\', \'Section of Endocrinology, Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0026-0495(20)30146-310.1016/j.metabol.2020.154282
?:doi
?:hasPublicationType
?:journal
  • Metabolism: clinical and experimental
is ?:pmid of
?:pmid
?:pmid
  • 32497535
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.285
?:rankingScore_hIndex
  • 116
is ?:relation_isRelatedTo_publication of
?:title
  • Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all